Skip to content

A 2-year Longitudinal Study on the Structural and Optical Effects of Orthokeratology Treatment on Eye

A 2-year Longitudinal Study on the Structural and Optical Effects of Orthokeratology Treatment on Eye

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02643342
Enrollment
99
Registered
2015-12-31
Start date
2016-06-18
Completion date
2019-08-03
Last updated
2020-07-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myopic Progression

Keywords

myopia control, orthokeratology

Brief summary

This is a two-year longitudinal study investigating the optical and structural effects of increased compression factor of orthokeratology lens on eyes and the corresponding effect on change in choroidal thickness and therefore myopic control.

Interventions

Sponsors

Menicon Co., Ltd.
CollaboratorINDUSTRY
Queensland University of Technology
CollaboratorOTHER
Aston University
CollaboratorOTHER
The Hong Kong Polytechnic University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
6 Years to 10 Years
Healthy volunteers
Yes

Inclusion criteria

* 6 to 10 years old * Myopia: between 0.50 D and 4.00 D in both eyes * Astigmatism: \<1.50 D; ≤ 1.25 D for with-the-rule astigmatism (axes 180 ± 30); ≤ 0.50 D for astigmatism of other axes in both eyes * Anisometropia: ≤ 1.50 D * Symmetrical corneal topography with corneal toricity \<2.00 D in both eyes * Agree for randomization

Exclusion criteria

* Contraindications for orthokeratology wear (e.g. limbus-to-limbus corneal cylinder and dislocated corneal apex) * Any type of strabismus or amblyopia * Myopic treatment (e.g. refractive surgery and progressive lens wear for myopic control) before and during the study period * Rigid contact lenses (including orthokeratology lenses) experience * Systemic condition which might affect refractive development (for example, Down syndrome, Marfan's syndrome) * Ocular conditions which might affect the refractive error (for example, cataract, ptosis) * Poor compliance for lens wear or follow-up

Design outcomes

Primary

MeasureTime frameDescription
Axial lengthevery 6 monthly in 2 yearsaxial progression of the eyeball

Secondary

MeasureTime frameDescription
Ocular aberration measured by Complete Ophthalmic Analysis System (COAS) aberrometerevery 6 monthly in 2 yearsocular aberration measured by Complete Ophthalmic Analysis System (COAS) aberrometer
Corneal biomechanics (corneal response using ocular response)every 6 monthly in 2 yearscorneal response using ocular response
Accommodation lag measured by Complete Ophthalmic Analysis System (COAS) aberrometerevery 6 monthly in 2 yearsaccommodation lag measured by Complete Ophthalmic Analysis System (COAS) aberrometer using different accommodation targets
Choroidal thickness captured by Optical Coherent Tomographer (OCT)every 6 monthly in 2 yearschoroidal thickness captured by Optical Coherent Tomographer (OCT) and measured using a customized software

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 18, 2026